Tolerability and activity of weekly paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Fabi, A
De Marco, S
Barduagni, M
Gamucci, T
Cortesi, E
De Marinis, F
Ferraresi, V
Saltarelli, R
Gabriele, A
Accettura, C
Cognetti, F
机构：
[1] Regina Elena Canc Inst, Rome, Italy
[2] ASL RMH, Rome, Italy
[3] Umberto I Hosp, Frosinone, Italy
[4] Umberto I Univ La Sapienza, Rome, Italy
[5] Forlanini Hosp, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A16
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [41] Phase II study of paclitaxel-carboplatin (PC) weekly combination chemotherapy in advanced non small cell lung cancer (NSCLC).
    Cerny, T
    D'Addario, G
    Morant, R
    ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
  • [42] Weekly treatment of non-small-cell lung (NSCLC) cancer patients with paclitaxel (P) and carboplatin (C)
    Schroeder, M
    Ukena, D
    Schutte, W
    Schroder, R
    Westerhausen, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1064 - 1064
  • [43] ACTIVITY AND TOLERABILITY OF CARBOPLATIN AND GEMCITABINE IN FIRST-LINE TREATMENT OF ELDERLY THAI PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Charoentum, Chaiyut
    Theerakittikul, Theerakorn
    Saeteng, Somcharone
    Euathrongchit, Juntima
    Lertprasertsuke, Nirush
    Ariyawutyakorn, Witthawat
    Chewaskulyong, Busyamas
    Thongprasert, Sumitra
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1313 - S1313
  • [44] Carboplatin plus Weekly Paclitaxel Treatment in Non-small Cell Lung Cancer Patients with Interstitial Lung Disease
    Shukuya, T.
    Ishiwata, T.
    Hara, M.
    Muraki, K.
    Shibayama, R.
    Koyama, R.
    Takahashi, K.
    ANTICANCER RESEARCH, 2010, 30 (10) : 4357 - 4361
  • [45] Study of three weekly nab-paclitaxel regimens in combination with carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC)
    Hawkins, M. J.
    Manikhas, G.
    Makhson, A.
    Cheporov, S.
    Orlov, S.
    Yablonsky, P.
    Bhar, P.
    Socinski, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] A dose-escalating and pharmacokinetic study of weekly combination chemotherapy with paclitaxel and carboplatin for unresectable non-small cell lung cancer (NSCLC)
    Kudo, Hiroyasu
    ANNALS OF ONCOLOGY, 2004, 15 : 180 - 181
  • [47] Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer
    Patricia M. M. B. Soetekouw
    Johanna N. H. Timmer-Bonte
    Miep A. van der Drift
    Frank van Leeuwen
    Michiel Wagenaar
    Lya van Die
    Jan Bussink
    Vivianne C. G. Tjan-Heijnen
    International Journal of Clinical Oncology, 2013, 18 : 988 - 996
  • [48] Induction chemotherapy with carboplatin and weekly paclitaxel followed by concomitant chemoradiation in locally advanced non-small cell lung cancer.
    Aydiner, A
    Topuz, E
    Eralp, Y
    Kaytan, E
    Oral, EN
    Kizir, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 683S - 683S
  • [49] A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer
    Dragnev, Konstantin H.
    Whyman, Jeremy D.
    Hahn, Cynthia K.
    Kebbekus, Peter E.
    Kokko, Sarah F.
    Bhatt, Sunil M.
    Rigas, James R.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5531 - 5537
  • [50] The feasibility of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias: a pilot study
    Kohno, A.
    Minegishi, Y.
    Sudoh, J.
    Kuribayashi, H.
    Shimokawa, T.
    Mizutani, H.
    Seike, M.
    Yoshimura, A.
    Gemma, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 531 - 531
12345